For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...
When I was diagnosed with colon cancer, I had a hard time deciding what my legacy should be, but once I realized what it was, ...
Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...
Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback